Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clinical Molecular Genetics Laboratory, |
RCV000582170 | SCV000692107 | pathogenic | Leydig cell agenesis | 2018-01-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002225682 | SCV002504605 | pathogenic | not provided | 2020-05-28 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 31980526) |
Genomic Medicine Center of Excellence, |
RCV000582170 | SCV005441986 | likely pathogenic | Leydig cell agenesis | 2024-12-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004754480 | SCV005353346 | likely pathogenic | LHCGR-related disorder | 2024-05-06 | no assertion criteria provided | clinical testing | The LHCGR c.370C>T variant is predicted to result in premature protein termination (p.Arg124*). This variant was reported in at least one participant from a study of adults who underwent deep phenotyping and genome sequencing. Limited clinical information was provided (Hou et al. 2020. PubMed ID: 31980526). This variant has not been reported in a large population database, indicating this variant is rare. Nonsense variants in LHCGR are expected to be pathogenic. This variant is interpreted as likely pathogenic. |